Clinical presentation of human C1q deficiency: How much of a lupus?
- PMID: 25846716
- DOI: 10.1016/j.molimm.2015.03.007
Clinical presentation of human C1q deficiency: How much of a lupus?
Abstract
Hereditary human C1q deficiency has been well described to be associated with high susceptibility for the development of systemic lupus erythematosus (SLE). The majority of subjects present a clinical syndrome closely related to SLE. However, limited information is available about the primary diagnosis and particular clinical manifestations of SLE in this specific subgroup of patients. In this review, we performed a comprehensive search of electronic databases up to November 2014 to identify and analyze reports on patients with C1q deficiency. We identified 71 C1q-deficient patients descending from 45 families that had been published. According to the American College of Rheumatology (ACR) diagnostic criteria for SLE 39/71 (55%) subjects could be classified as having SLE. Another 16/71 (22.5%) presented a SLE-like syndrome (defined as 3 positive ACR criteria) whereas in 16/71 (22.5%) no SLE could be diagnosed at time of publication. Symptoms began at a median age of 5 years, male and females being equally affected. Discoid rash (56% versus 10%, p<0.001) and oral ulcers (49% versus 24%, p<0.001) occurred significantly more frequent in C1q deficiency-associated SLE/SLE-like disease than in sporadic SLE, whereas arthritis (38% versus 84%, p<001) and anti-ds-DNA (18% versus 78%, p<0.001) occurred less frequently. Renal and neurological manifestations were found to occur similarly frequent. The severe course of disease in some patients seemed to be mostly due to severe infections at early ages and not in particular due to more aggressive SLE manifestations.
Keywords: ACR diagnostic criteria; C1q deficiency; Review; Systemic lupus erythematosus.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.Lupus. 2012 Jan;21(1):36-42. doi: 10.1177/0961203311422094. Epub 2011 Oct 12. Lupus. 2012. PMID: 21993384
-
Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency.J Autoimmun. 2015 Aug;62:39-44. doi: 10.1016/j.jaut.2015.06.002. Epub 2015 Jun 26. J Autoimmun. 2015. PMID: 26119135
-
Monogenic interferonopathies: Phenotypic and genotypic findings of CANDLE syndrome and its overlap with C1q deficient SLE.Int J Rheum Dis. 2018 Jan;21(1):208-213. doi: 10.1111/1756-185X.13228. Epub 2017 Nov 8. Int J Rheum Dis. 2018. PMID: 29115062
-
Hereditary C1q deficiency and systemic lupus erythematosus.QJM. 1994 Aug;87(8):455-64. QJM. 1994. PMID: 7922299 Review.
-
Diagnostic criteria for systemic lupus erythematosus: a critical review.J Autoimmun. 2014 Feb-Mar;48-49:10-3. doi: 10.1016/j.jaut.2014.01.004. Epub 2014 Jan 21. J Autoimmun. 2014. PMID: 24461385 Review.
Cited by
-
Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma.Onco Targets Ther. 2021 Mar 5;14:1737-1751. doi: 10.2147/OTT.S295063. eCollection 2021. Onco Targets Ther. 2021. PMID: 33707956 Free PMC article.
-
Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis.EBioMedicine. 2018 Jun;32:21-30. doi: 10.1016/j.ebiom.2018.05.034. Epub 2018 Jun 7. EBioMedicine. 2018. PMID: 29885865 Free PMC article.
-
The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis.Neurotherapeutics. 2020 Oct;17(4):1768-1784. doi: 10.1007/s13311-020-00950-2. Epub 2020 Oct 14. Neurotherapeutics. 2020. PMID: 33058021 Free PMC article. Review.
-
Balancing the View of C1q in Transplantation: Consideration of the Beneficial and Detrimental Aspects.Front Immunol. 2022 Mar 24;13:873479. doi: 10.3389/fimmu.2022.873479. eCollection 2022. Front Immunol. 2022. PMID: 35401517 Free PMC article. No abstract available.
-
Efficacy and mechanisms underlying the effects of allogeneic umbilical cord mesenchymal stem cell transplantation on acute radiation injury in tree shrews.Cytotechnology. 2018 Oct;70(5):1447-1468. doi: 10.1007/s10616-018-0239-z. Epub 2018 Jul 31. Cytotechnology. 2018. PMID: 30066056 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical